Volume 19, Issue 4 pp. 554-557

Early (mucosal) gastric cancer with synchronous osteosclerotic bone metastases: a case report

G. ANAGNOSTOPOULOS md

G. ANAGNOSTOPOULOS md

Department of Gastroenterology, 251 Hellenic Air Force Hospital, Athens

Search for more papers by this author
G.H. SAKORAFAS md

Corresponding Author

G.H. SAKORAFAS md

Department of Surgery, 251 Hellenic Air Force Hospital, Athens

George H. Sakorafas, Arkadias 19–21, GR−115 26 Athens, Greece (e-mail: [email protected]).Search for more papers by this author
P. KOSTOPOULOS md

P. KOSTOPOULOS md

Department of Gastroenterology, 251 Hellenic Air Force Hospital, Athens

Search for more papers by this author
G. MARGANTINIS md

G. MARGANTINIS md

Department of Gastroenterology, 251 Hellenic Air Force Hospital, Athens

Search for more papers by this author
S. TSIAKOS md

S. TSIAKOS md

Department of Gastroenterology, 251 Hellenic Air Force Hospital, Athens

Search for more papers by this author
G. PAVLAKIS md

G. PAVLAKIS md

Department of Oncology 251 Hellenic Air Force Hospital, Athens, Greece

Search for more papers by this author
First published: 15 June 2010
Citations: 12

Abstract

ANAGNOSTOPOULOS G., SAKORAFAS G.H., KOSTOPOULOS P., MARGANTINIS G., TSIAKOS S. & PAVLAKIS G. (2010) European Journal of Cancer Care
Early (mucosal) gastric cancer with synchronous osteosclerotic bone metastases: a case report

Early gastric cancer (EGC) is defined as an adenocarcinoma confined to the gastric mucosa or submucosa, regardless of the presence of lymph node metastases. Early gastric cancer carries an excellent prognosis, with a 5-year survival rate at least 85% in most series. However, there are rare cases where distant metastases exist. Bone metastases are rare in gastric cancer; osteoblastic bone metastases are even rarer. We report a patient with EGC (mucosal) and synchronous osteosclerotic bone metastasis. To our knowledge, this is the first reported case of submucosal EGC with synchronous bone metastases. The patient was operated and he received adjuvant chemotherapy and radiotherapy. He died 18 months after gastric surgery from generalized disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.